Article
[Hemophilia B replacement therapy drugs].
Sheng wu gong cheng xue bao = Chinese journal of biotechnology - 1 Feb 2016
Yan Hong, Zeng Fanyi
Abstract excerpt
Hemophilia B is an X chromosome linked hereditary hemorrhagic disease, which is caused by the lose function mutation of factor IX (FIX), and significantly affects the patients' lifespan and life quality. The severity of hemophilia B depends on the FIX level in the plasma. By referring to the relevant literatures, we reviewed and summarized hemophilia B replacement therapies. Specifically, we focus on recombinant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
